健康绝经前女性乳腺癌危险因素与循环抗苗勒管激素浓度的关联
该横断面研究纳入10个队列的3831名健康绝经前女性,分析乳腺癌危险因素与抗苗勒管激素(AMH)浓度的关联。结果显示AMH与初潮年龄、产次正相关,与子宫切除/部分卵巢切除、肥胖、当前口服避孕药使用及吸烟负相关,且多数关联仅限于40岁及以上女性。
要点
- AMH与初潮年龄、产次呈正相关,与子宫切除/部分卵巢切除呈负相关。
- 肥胖、当前口服避孕药使用及当前/既往吸烟与较低AMH浓度相关。
- 良性乳腺活检史与较高AMH相关,且多数关联仅限于40岁及以上女性。
核心结论
- 在一般人群(非不孕就诊)的健康绝经前女性中,AMH与多数乳腺癌危险因素的关联仅限于40岁及以上、接近绝经且AMH浓度下降的女性。
研究设计与样本
- 横断面研究,纳入来自10个一般人群队列研究的3831名健康绝经前女性(年龄21-57岁,87%为35-49岁)。
主要发现
- 调整年龄和队列后,AMH与初潮年龄(P < 0.0001)和产次(P = 0.0008)正相关,与子宫切除/部分卵巢切除(P = 0.0008)负相关。
- 与正常体重女性相比,肥胖女性AMH较低(相对几何均值差异27%,P < 0.0001)。
- 当前口服避孕药使用者和当前/既往吸烟者AMH浓度分别比从未使用者低40%和12%(P < 0.0001)。
- 有良性乳腺活检史的女性AMH浓度高15%(P = 0.03)。
- 按年龄分层(<40岁 vs ≥40岁),AMH与体重指数和口服避孕药的关联在两组相似,而与其他因素(初潮、产次、子宫切除/部分卵巢切除、吸烟、良性乳腺活检)的关联仅限于≥40岁女性(交互作用P < 0.05)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: We previously reported that anti-Müllerian hormone (AMH), a marker of ovarian reserve, is positively associated with breast cancer risk, consistent with other studies. OBJECTIVE: This study assessed whether risk factors for breast cancer are correlates of AMH concentration. METHODS: This cross-sectional study included 3831 healthy premenopausal women (aged 21-57, 87% aged 35-49) from 10 cohort studies among the general population. RESULTS: Adjusting for age and cohort, AMH positively associated with age at menarche (P < 0.0001) and parity (P = 0.0008) and inversely associated with hysterectomy/partial oophorectomy (P = 0.0008). Compared with women of normal weight, AMH was lower (relative geometric mean difference 27%, P < 0.0001) among women who were obese. Current oral contraceptive (OC) use and current/former smoking were associated with lower AMH concentration than never use (40% and 12% lower, respectively, P < 0.0001). We observed higher AMH concentrations among women who had had a benign breast biopsy (15% higher, P = 0.03), a surrogate for benign breast disease, an association that has not been reported. In analyses stratified by age (<40 vs ≥40), associations of AMH with body mass index and OCs were similar in younger and older women, while associations with the other factors (menarche, parity, hysterectomy/partial oophorectomy, smoking, and benign breast biopsy) were limited to women ≥40 (P-interaction < 0.05). CONCLUSION: This is the largest study of AMH and breast cancer risk factors among women from the general population (not presenting with infertility), and it suggests that most associations are limited to women over 40, who are approaching menopause and whose AMH concentration is declining.
引用
- Clendenen TV, Ge W, Koenig KL, et al. Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women. J Clin Endocrinol Metab. 2021. PMID: 34157104. doi:10.1210/clinem/dgab461
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。